Recent Broker Recommendations
UBS 01-Aug-12
Target $10.12 (was $10.03). Given there is no production, there is also no June quarter revenue, although the company's cash balance was slightly above UBS' forecast.
However, the broker continues to see plenty of valuation upside, with current drilling in Brazil leading the broker's list of possible catalysts. Buy call maintained.
Buy
Credit Suisse 01-Aug-12
Drilling at Browse has been beset with mechanical problems and Karoon's Brazilian testing has been delayed as well.
The broker remains a fan, however. No changes.
Outperform
- Forums
- ASX - By Stock
- KAR
- brokers and fidelity management and research
KAR
karoon energy ltd
Add to My Watchlist
1.05%
!
$1.89

brokers and fidelity management and research, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.89 |
Change
-0.020(1.05%) |
Mkt cap ! $1.392B |
Open | High | Low | Value | Volume |
$1.92 | $1.93 | $1.88 | $4.459M | 2.351M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5375 | $1.89 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.90 | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5375 | 1.885 |
1 | 50000 | 1.880 |
4 | 73752 | 1.875 |
1 | 14750 | 1.870 |
2 | 5913 | 1.860 |
Price($) | Vol. | No. |
---|---|---|
1.900 | 5000 | 1 |
1.910 | 14800 | 1 |
1.915 | 14740 | 1 |
1.920 | 165148 | 2 |
1.925 | 2346 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
KAR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online